<p>隨着歐洲的 STOXX 600 指數在對未來收益和經濟復甦的樂觀情緒中徘徊於歷史高位，投資者越來越關注那些擁有大量內部持股的成長型公司。這些公司通常反映出與業務最親近的人士的強烈信心，使其在謹慎樂觀的市場環境中顯得尤為吸引人。</p>
<h3>歐洲內部持股比例高的十大成長型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>Warimpex Finanz- und Beteiligungs (WBAG:WXF)</td>
<td>25.9%</td>
<td>100.6%</td>
</tr>
<tr>
<td>S.M.A.I.O (ENXTPA:ALSMA)</td>
<td>16.1%</td>
<td>72.8%</td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>83%</td>
</tr>
<tr>
<td>Magnora (OB:MGN)</td>
<td>10.4%</td>
<td>75.1%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>61.2%</td>
</tr>
<tr>
<td>Guard Therapeutics International (OM:GUARD)</td>
<td>13.1%</td>
<td>103.3%</td>
</tr>
<tr>
<td>DNO (OB:DNO)</td>
<td>13.5%</td>
<td>97.5%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.5%</td>
<td>52%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>24.1%</td>
<td>66.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.4%</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們關於內部持股比例高的快速成長歐洲公司的 208 只股票的完整列表。</p>
<p>讓我們更仔細地看看我們從篩選公司中挑選的幾家公司。</p>
<h2>CTT Systems (OM:CTT)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★★</p>
<p><strong>概述：</strong> CTT Systems AB (publ) 在瑞典、丹麥、法國、美國及其他國際市場開發和提供飛機濕度控制系統，市值為 25 億瑞典克朗。</p>
<p><strong>運營：</strong> CTT Systems AB 的收入來自其航空航天與國防部門，金額為 2.912 億瑞典克朗。</p>
<p><strong>內部持股：</strong> 17.5%</p>
<p><strong>股本回報率預測：</strong> 45%（2028 年估計）</p>
<p>CTT Systems 展現出強勁的增長潛力，預計收益將以每年 52% 的速度顯著增長，超過瑞典市場。收入預計每年增長 25.2%，同樣高於市場水平。儘管交易價格大幅低於估計的公允價值，但最近的業績顯示出混合表現，利潤率下降，九個月的淨收入較去年有所減少。2.69% 的股息收益率缺乏收益或自由現金流的支持。</p>
<ul>
<li>解鎖我們對 CTT Systems 股票分析的全面見解，盡在本成長報告中。</li>
<li>我們的 CTT Systems 估值報告中的分析暗示其股價相較於估計值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown"/></p>
<p>截至 2026 年 1 月的 OM:CTT 持股分佈</p>
<h2>Lime Technologies (OM:LIME)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Lime Technologies AB (publ) 主要在北歐地區提供基於 SaaS 的 CRM 解決方案，市值約為 38.2 億瑞典克朗。</p>
<p><strong>運營：</strong> 公司的收入主要來自銷售和實施 CRM 軟件系統，金額約為 7.3163 億瑞典克朗。</p>
<p><strong>內部持股：</strong> 10.4%</p>
<p><strong>股本回報率預測：</strong> 32%（2028 年估計）</p>
<p>Lime Technologies 展現出強勁的增長前景，預計收益將以每年 20.8% 的速度顯著增長，超過瑞典市場水平。收入預計以每年 10.8% 的速度增長，但仍高於市場平均水平。該公司交易價格顯著低於其估計的公允價值，最近的高管變動表明未來擴展階段的戰略一致性。第三季度的業績報告顯示銷售和淨收入增加，反映出持續的運營實力。</p>
<ul>
<li>點擊這裏瞭解 Lime Technologies 的細微差別，獲取我們的詳細分析未來增長報告。</li>
<li>我們最近的估值報告指出 Lime Technologies 的股票在市場上可能被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown"/></p>
<p>截至 2026 年 1 月的 OM:LIME 持股分佈</p>
<h2>Medicover (OM:MCOV B)</h2>
<p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Medicover AB (publ) 在波蘭、瑞典及國際上運營醫療和診斷服務，市值為 332.9 億瑞典克朗。</p>
<p><strong>運營：</strong> 該公司從兩個主要部門產生收入：醫療服務收入為 16.2 億歐元，診斷服務收入為 7.321 億歐元。</p>
<p><strong>內部持股：</strong> 11.2%</p>
<p><strong>股本回報率預測：</strong> 24%（2028 年估計）</p>
<p>Medicover 展現出良好的增長前景，預計收益將以每年 25.1% 的速度顯著增長，超過瑞典市場。收入預計以每年 10.8% 的速度增長，快於市場平均水平。最近的內部購買相當可觀，表明對未來前景的信心。該公司交易價格低於其公允價值估計，第三季度的業績顯示銷售增加並恢復盈利，突顯出運營改善和在 MRD 檢測開發中的戰略進展。</p>
<ul>
<li>在我們的收益增長報告中更仔細地看看 Medicover 的潛力。</li>
<li>我們的全面估值報告提出 Medicover 的價格可能低於其財務狀況所能證明的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth"/></p>
<p>截至 2026 年 1 月的 OM:MCOV B 收益和收入增長</p>
<h2>利用機會</h2>
<ul>
<li>點擊這裏揭示我們快速成長的歐洲公司中 208 個隱藏的寶石。</li>
<li>準備進入其他投資風格嗎？特朗普承諾要 “釋放” 美國的石油和天然氣，這 22 只美國股票的發展有望受益。</li>
</ul>
<p>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有引用的預測收入和盈利增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</p>
<p>國防與災難的移動基礎設施</p>
<p>下一波機器人技術不是類人型的，而是完全自主的塔樓，能夠在 30 分鐘內提供 5G、ISR 和雷達服務，覆蓋任何地點。</p>
<p>在下一輪合同之前獲取投資者簡報</p>
<p>由 CiTech 贊助</p>

<p>隨着歐洲的 STOXX 600 指數接近歷史高點，投資者正關注那些內部持股比例高的成長型公司，這表明了強烈的信心。值得注意的公司包括 Warimpex Finanz- und Beteiligungs（內部持股 25.9%，盈利增長 100.6%）、S.M.A.（16.1%，72.8%）和 CTT Systems（17.5%，52%）。儘管近期表現不一，CTT Systems 仍顯示出潛力，預計年盈利增長 52%。Lime Technologies（10.4% 持股，20.8% 增長）和 Medicover（11.2%，25.1%）也展現出強勁的增長前景，交易價格低於公允價值。分析強調了在謹慎樂觀的市場中，這些公司的吸引力</p>

<p>As Europe’s STOXX 600 Index hovers near record highs amid optimism about future earnings and economic recovery, investors are increasingly focusing on growth companies with substantial insider ownership. Such companies often reflect strong confidence from those closest to the business, making them attractive in a market environment where cautious optimism prevails.</p>
<div class="lb-trans"><p>隨着歐洲的 STOXX 600 指數在對未來收益和經濟復甦的樂觀情緒中徘徊於歷史高位，投資者越來越關注那些擁有大量內部持股的成長型公司。這些公司通常反映出與業務最親近的人士的強烈信心，使其在謹慎樂觀的市場環境中顯得尤為吸引人。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Europe</h3>
<div class="lb-trans"><h3>歐洲內部持股比例高的十大成長型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Warimpex Finanz- und Beteiligungs (WBAG:WXF)</td>
<td>25.9%</td>
<td>100.6%</td>
</tr>
<tr>
<td>S.M.A.I.O (ENXTPA:ALSMA)</td>
<td>16.1%</td>
<td>72.8%</td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>83%</td>
</tr>
<tr>
<td>Magnora (OB:MGN)</td>
<td>10.4%</td>
<td>75.1%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>61.2%</td>
</tr>
<tr>
<td>Guard Therapeutics International (OM:GUARD)</td>
<td>13.1%</td>
<td>103.3%</td>
</tr>
<tr>
<td>DNO (OB:DNO)</td>
<td>13.5%</td>
<td>97.5%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.5%</td>
<td>52%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>24.1%</td>
<td>66.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.4%</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>收益增長</strong></td>
</tr>
<tr>
<td>Warimpex Finanz- und Beteiligungs (WBAG:WXF)</td>
<td>25.9%</td>
<td>100.6%</td>
</tr>
<tr>
<td>S.M.A.I.O (ENXTPA:ALSMA)</td>
<td>16.1%</td>
<td>72.8%</td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>83%</td>
</tr>
<tr>
<td>Magnora (OB:MGN)</td>
<td>10.4%</td>
<td>75.1%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>36.3%</td>
<td>61.2%</td>
</tr>
<tr>
<td>Guard Therapeutics International (OM:GUARD)</td>
<td>13.1%</td>
<td>103.3%</td>
</tr>
<tr>
<td>DNO (OB:DNO)</td>
<td>13.5%</td>
<td>97.5%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.5%</td>
<td>52%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>24.1%</td>
<td>66.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.4%</td>
<td>49.7%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 208 stocks from our Fast Growing European Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們關於內部持股比例高的快速成長歐洲公司的 208 只股票的完整列表。</p>
</div><p>Let's take a closer look at a couple of our picks from the screened companies.</p>
<div class="lb-trans"><p>讓我們更仔細地看看我們從篩選公司中挑選的幾家公司。</p>
</div><h2>CTT Systems (OM:CTT)</h2>
<div class="lb-trans"><h2>CTT Systems (OM:CTT)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> CTT Systems AB (publ) develops and supplies humidity control systems for aircraft across Sweden, Denmark, France, the United States, and other international markets, with a market cap of SEK2.50 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> CTT Systems AB (publ) 在瑞典、丹麥、法國、美國及其他國際市場開發和提供飛機濕度控制系統，市值為 25 億瑞典克朗。</p>
</div><p><strong>Operations:</strong> CTT Systems AB generates revenue from its Aerospace &amp; Defense segment, amounting to SEK291.20 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> CTT Systems AB 的收入來自其航空航天與國防部門，金額為 2.912 億瑞典克朗。</p>
</div><p><strong>Insider Ownership:</strong> 17.5%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 17.5%</p>
</div><p><strong>Return On Equity Forecast:</strong> 45% (2028 estimate)</p>
<div class="lb-trans"><p><strong>股本回報率預測：</strong> 45%（2028 年估計）</p>
</div><p>CTT Systems exhibits strong growth potential with earnings forecasted to grow significantly at 52% annually, outpacing the Swedish market. Revenue is expected to rise by 25.2% per year, also above market rates. Despite trading at a substantial discount to estimated fair value, recent results show mixed performance with declining profit margins and lower nine-month net income compared to last year. The dividend yield of 2.69% lacks coverage from earnings or free cash flow.</p>
<div class="lb-trans"><p>CTT Systems 展現出強勁的增長潛力，預計收益將以每年 52% 的速度顯著增長，超過瑞典市場。收入預計每年增長 25.2%，同樣高於市場水平。儘管交易價格大幅低於估計的公允價值，但最近的業績顯示出混合表現，利潤率下降，九個月的淨收入較去年有所減少。2.69% 的股息收益率缺乏收益或自由現金流的支持。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of CTT Systems stock in this growth report.</li>
<li>The analysis detailed in our CTT Systems valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖我們對 CTT Systems 股票分析的全面見解，盡在本成長報告中。</li>
<li>我們的 CTT Systems 估值報告中的分析暗示其股價相較於估計值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/0b9f83b6-98fc-4082-8f80-2e0fce91d9b4/chart/ownership-breakdown"/></p>
<p>OM:CTT Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 OM:CTT 持股分佈</p>
</div><h2>Lime Technologies (OM:LIME)</h2>
<div class="lb-trans"><h2>Lime Technologies (OM:LIME)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Lime Technologies AB (publ) offers SaaS-based CRM solutions primarily in the Nordic region and has a market capitalization of approximately SEK3.82 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Lime Technologies AB (publ) 主要在北歐地區提供基於 SaaS 的 CRM 解決方案，市值約為 38.2 億瑞典克朗。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from selling and implementing CRM software systems, amounting to approximately SEK731.63 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 公司的收入主要來自銷售和實施 CRM 軟件系統，金額約為 7.3163 億瑞典克朗。</p>
</div><p><strong>Insider Ownership:</strong> 10.4%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 10.4%</p>
</div><p><strong>Return On Equity Forecast:</strong> 32% (2028 estimate)</p>
<div class="lb-trans"><p><strong>股本回報率預測：</strong> 32%（2028 年估計）</p>
</div><p>Lime Technologies demonstrates robust growth prospects with earnings expected to grow significantly at 20.8% annually, surpassing the Swedish market rate. Revenue is forecasted to increase at a slower pace of 10.8% per year but still above market averages. The company trades at a notable discount to its estimated fair value, and recent executive changes suggest strategic alignment for future expansion phases. Third-quarter results reported increased sales and net income, reflecting ongoing operational strength.</p>
<div class="lb-trans"><p>Lime Technologies 展現出強勁的增長前景，預計收益將以每年 20.8% 的速度顯著增長，超過瑞典市場水平。收入預計以每年 10.8% 的速度增長，但仍高於市場平均水平。該公司交易價格顯著低於其估計的公允價值，最近的高管變動表明未來擴展階段的戰略一致性。第三季度的業績報告顯示銷售和淨收入增加，反映出持續的運營實力。</p>
</div><ul>
<li>Click here to discover the nuances of Lime Technologies with our detailed analytical future growth report.</li>
<li>Insights from our recent valuation report point to the potential undervaluation of Lime Technologies shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏瞭解 Lime Technologies 的細微差別，獲取我們的詳細分析未來增長報告。</li>
<li>我們最近的估值報告指出 Lime Technologies 的股票在市場上可能被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/3ca4bc24-fcf9-458b-9c13-3dbebb04ed91/chart/ownership-breakdown"/></p>
<p>OM:LIME Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 OM:LIME 持股分佈</p>
</div><h2>Medicover (OM:MCOV B)</h2>
<div class="lb-trans"><h2>Medicover (OM:MCOV B)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Medicover AB (publ) operates healthcare and diagnostic services in Poland, Sweden, and internationally with a market cap of SEK33.29 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Medicover AB (publ) 在波蘭、瑞典及國際上運營醫療和診斷服務，市值為 332.9 億瑞典克朗。</p>
</div><p><strong>Operations:</strong> The company generates revenue from two main segments: €1.62 billion from Healthcare Services and €732.10 million from Diagnostic Services.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司從兩個主要部門產生收入：醫療服務收入為 16.2 億歐元，診斷服務收入為 7.321 億歐元。</p>
</div><p><strong>Insider Ownership:</strong> 11.2%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 11.2%</p>
</div><p><strong>Return On Equity Forecast:</strong> 24% (2028 estimate)</p>
<div class="lb-trans"><p><strong>股本回報率預測：</strong> 24%（2028 年估計）</p>
</div><p>Medicover shows promising growth with earnings expected to rise significantly at 25.1% annually, outpacing the Swedish market. Revenue is forecasted to grow at 10.8% per year, faster than the market average. Insider buying has been substantial recently, indicating confidence in future prospects. The company trades below its fair value estimate and third-quarter results revealed increased sales and a return to profitability, highlighting operational improvements and strategic advancements in their MRD assay development.</p>
<div class="lb-trans"><p>Medicover 展現出良好的增長前景，預計收益將以每年 25.1% 的速度顯著增長，超過瑞典市場。收入預計以每年 10.8% 的速度增長，快於市場平均水平。最近的內部購買相當可觀，表明對未來前景的信心。該公司交易價格低於其公允價值估計，第三季度的業績顯示銷售增加並恢復盈利，突顯出運營改善和在 MRD 檢測開發中的戰略進展。</p>
</div><ul>
<li>Take a closer look at Medicover's potential here in our earnings growth report.</li>
<li>Our comprehensive valuation report raises the possibility that Medicover is priced lower than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的收益增長報告中更仔細地看看 Medicover 的潛力。</li>
<li>我們的全面估值報告提出 Medicover 的價格可能低於其財務狀況所能證明的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/12b417bf-5706-4899-9ca5-59fa1e6ea4cc/chart/earnings-and-revenue-growth"/></p>
<p>OM:MCOV B Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>截至 2026 年 1 月的 OM:MCOV B 收益和收入增長</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用機會</h2>
</div><ul>
<li>Reveal the 208 hidden gems among our Fast Growing European Companies With High Insider Ownership screener with a single click here.</li>
<li>Ready To Venture Into Other Investment Styles? Trump has pledged to &#34;unleash&#34; American oil and gas and these 22 US stocks have developments that are poised to benefit.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏揭示我們快速成長的歐洲公司中 208 個隱藏的寶石。</li>
<li>準備進入其他投資風格嗎？特朗普承諾要 “釋放” 美國的石油和天然氣，這 22 只美國股票的發展有望受益。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏見的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買賣任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有引用的預測收入和盈利增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>國防與災難的移動基礎設施</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波機器人技術不是類人型的，而是完全自主的塔樓，能夠在 30 分鐘內提供 5G、ISR 和雷達服務，覆蓋任何地點。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一輪合同之前獲取投資者簡報</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 贊助</p>
</div>

2026 年 1 月歐洲內部持股比例高的成長型公司